Accuray Incorporated announced the appointment of Mika Nishimura to the company's Board of Directors, effective as of August 17, 2021. With Ms. Nishimura's appointment, the Accuray Board will consist of nine members. Ms. Nishimura also currently serves as an Independent Director on the Boards of SI-BONE Inc., and MobileODT, and as a Board advisor to Tristel, plc. A commercial business executive with more than 25 years of global medical device industry experience, Ms. Nishimura has deep product commercialization experience across a broad range of innovative medical technologies. For the last 10 years, Ms. Nishimura has been an Operational Partner with Gilde Healthcare Partners, where she has been an integral member of the investment team and contributed to the fund's success with over 12 company exit events. In her most recent executive position, Ms. Nishimura was Vice President, Commercialization at nVision Medical Corporation.